| Date Filed | Type | Description |
| 08/15/2023 |
4
| Oki Mark K (CFO) has filed a Form 4 on AYTU BIOPHARMA, INC|
Txns:
| Granted 13,000 options to buy
@ $1.73, valued at
$22.5k
|
|
| 11/28/2022 |
4/A
| Oki Mark K (CFO) has filed a Form 4 on AYTU BIOPHARMA, INC|
Txns:
| Bought 90,000 shares
@ $0.23, valued at
$20.7k
|
|
| 11/21/2022 |
4
| Oki Mark K (CFO) has filed a Form 4 on AYTU BIOPHARMA, INC|
Txns:
| Granted 90,000 shares
@ $0.23, valued at
$20.7k
|
|
| 01/19/2022 |
4
| Oki Mark K (CFO) has filed a Form 4 on AYTU BIOPHARMA, INC|
Txns:
| Granted 100,000 shares
@ $0 |
|
| 01/19/2022 |
3
| Oki Mark K (CFO) has filed a Form 3 on AYTU BIOPHARMA, INC |
| 01/31/2020 |
4
| Oki Mark K (CFO & CAO) has filed a Form 4 on VIVUS INC|
Txns:
| Granted 32,000 options to buy
@ $2.21, valued at
$70.7k
|
|
| 11/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/15/2019 |
4
| Oki Mark K (SVP, CFO, CAO) has filed a Form 4 on VIVUS INC|
Txns:
| Granted 700 shares
@ $2.84, valued at
$2k
|
|
| 01/25/2019 |
4
| Oki Mark K (CFO & CAO) has filed a Form 4 on VIVUS INC|
Txns:
| Granted 32,000 options to buy
@ $4.05, valued at
$129.6k
|
|
| 11/16/2018 |
4
| Oki Mark K (CFO & CAO) has filed a Form 4 on VIVUS INC|
Txns:
| Granted 700 shares
@ $2.71, valued at
$1.9k
|
|
| 11/07/2018 |
4
| Oki Mark K (CFO & CAO) has filed a Form 4 on VIVUS INC|
Txns:
| Bought 10,000 shares
@ $4.07, valued at
$40.7k
|
|
| 05/02/2018 |
4
| Oki Mark K (CFO & CAO) has filed a Form 4 on VIVUS INC|
Txns:
| Granted 200,000 options to buy
@ $0.37, valued at
$74k
|
|
| 02/06/2018 |
4
| Oki Mark K (CFO & CAO) has filed a Form 4 on VIVUS INC|
Txns:
| Granted 350,000 options to buy
@ $0.4, valued at
$140k
|
|
| 01/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/26/2016 |
4
| Oki Mark K (CFO & CAO) has filed a Form 4 on VIVUS INC|
Txns:
| Granted 93,500 options to buy
@ $1.06, valued at
$99.1k
|
|
| 01/19/2016 |
4
| Oki Mark K (Former SVP, CFO, Secretary) has filed a Form 4 on Alexza Pharmaceuticals Inc. |
| 11/03/2015 |
4
| Oki Mark K (CFO & CAO) has filed a Form 4 on VIVUS INC|
Txns:
| Granted 225,000 options to buy
@ $1.26, valued at
$283.5k
|
|
| 07/24/2015 |
4
| Oki Mark K (SVP, Finance, CFO & Sec) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Granted 125,000 options to buy
@ $1.08, valued at
$135k
Granted 125,000 options to buy
@ $1.08, valued at
$135k
|
|
| 11/03/2014 |
4
| Oki Mark K (SVP, CFO & Secretary) has filed a Form 4 on Alexza Pharmaceuticals Inc. |
| 06/30/2014 |
4
| Oki Mark K (SVP, CFO & Secretary) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Granted 50,000 options to buy
@ $4.57, valued at
$228.5k
|
|
| 05/01/2014 |
4
| Oki Mark K (SVP, CFO & Secretary) has filed a Form 4 on Alexza Pharmaceuticals Inc. |
| 11/04/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/01/2013 |
4
| Oki Mark K (SVP, CFO and Sec) has filed a Form 4 on Alexza Pharmaceuticals Inc. |
| 11/01/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/29/2012 |
4
| Oki Mark K (SVP, CFO and Sec) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Sold 10,000 shares
@ $4.1364, valued at
$41.4k
|
|
| 06/08/2012 |
4
| Oki Mark K (VP Fin Controller PAO PFO Sec) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Sold 31,873 shares
@ $0.3381, valued at
$10.8k
|
|
| 05/14/2012 |
4
| Oki Mark K (VP Fin Controller PAO PFO Sec) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Granted 100,000 shares
@ $0 |
|
| 03/26/2012 |
4
| Oki Mark K (VP Fin Controller PAO PFO Sec) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Granted 31,873 shares
@ $0 |
|
| 08/01/2011 |
4
| Oki Mark K (VP Fin, Controller & PAO) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Granted 110,000 options to buy
@ $1.53, valued at
$168.3k
|
|
| 05/05/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/27/2010 |
3/A
| Oki Mark K (VP Fin, Controller & PAO) has filed a Form 3/A on Alexza Pharmaceuticals Inc. |
| 05/20/2010 |
3
| Oki Mark K (VP Fin, Controller & PAO) has filed a Form 3 on Alexza Pharmaceuticals Inc. |